Related Experiment Videos
Irradiation therapy: from UV light to electron beam
1Department of Dermatalogy, University Hospital CHUV, Lausanne, Switzerland. renato.panizzon@chuv.ch
Journal of Cutaneous Pathology
|January 18, 2006
Summary
Irradiation therapy, including UV and radiation, is key for cutaneous T-cell lymphomas. Narrowband UVB, PUVA, and electron beam radiation offer effective treatment options for various disease stages.
Area of Science:
- Dermatology
- Oncology
- Radiation Oncology
Background:
- Cutaneous T-cell lymphomas (CTCL) are a group of malignant skin conditions.
- Irradiation therapy is a primary treatment modality for CTCL.
Purpose of the Study:
- To review the role and efficacy of various irradiation-based therapies in managing CTCL.
- To highlight treatment options for different stages and severities of CTCL.
Main Methods:
- Review of existing literature on UV therapy (broadband UVB, narrowband UVB, PUVA) and radiotherapy (conventional, electron beam) for CTCL.
- Discussion of treatment selection based on disease stage and resistance.
Main Results:
- Narrowband UVB is more effective than broadband UVB for patch and plaque stages.
- PUVA therapy is effective for advanced stages, including erythrodermic CTCL.
- Electron beam therapy and total skin electron beam radiation are effective for resistant cases and widespread disease.
Conclusions:
- Various forms of irradiation therapy are essential for CTCL management.
- Treatment choice depends on disease stage, with options including UV, PUVA, and electron beam radiation.
- Combination therapies (UV with radiation, chemo-, or immunotherapy) may enhance outcomes.